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Sensitive, high-throughput methods to detect malaria parasites in low-transmission settings are needed.
PCR-based pooling strategies may offer a solution. We first used laboratory-prepared samples to compare 2
DNA extraction and 4 PCR detection methods across a range of pool sizes and parasite densities. Pooled
Chelex extraction of DNA, followed by nested PCR of cytochrome b, was the optimal strategy, allowing reliable
detection of a single low-parasitemic sample (100 parasites/l) in pool sizes up to 50. This PCR-based pooling
strategy was then compared with microscopy using 891 dried blood spots from a cohort of 77 Ugandan children
followed for 2 years in an urban setting of low endemicity. Among 419 febrile episodes, 35 cases of malaria were
detected using the PCR-based pooling strategy and 40 cases using microscopy. All five cases of malaria not
detected by PCR were from samples stored for >2 years with parasitemia of <6,000/l, highlighting the issue
of possible DNA degradation with long-term storage of samples. Among 472 samples collected from asymp-
tomatic children as part of routine surveillance, 15 (3.2%) were positive by PCR-based pooling compared to 4
(0.8%) by microscopy (P  0.01). Thus, this PCR-based pooling strategy for detection of malaria parasites
using dried blood spots offers a sensitive and efficient approach for malaria surveillance in low-transmission
settings, enabling improved detection of asymptomatic submicroscopic infections and dramatic savings in
labor and costs.
Due to large-scale implementation of effective control mea-
sures, many countries where malaria is endemic are experienc-
ing dramatic declines in disease burden. With this success has
come a shift in the end goal from control to elimination (9, 10).
However, when the goal is elimination, accurate detection of
persons infected with malaria parasites becomes essential (11).
Standard surveillance systems depend on diagnosis by micros-
copy, a method that is technically challenging, labor-intensive,
and often inaccurate in operational settings. More recently
available rapid diagnostic tests (RDTs) provide convenience
and ease of use, but they have limitations in specificity, sensi-
tivity, species identification, and cost (22).
PCR-based methods for malaria parasite detection are rel-
atively simple and provide improved sensitivity compared to
microscopy and RDTs, especially in settings where infections
have low parasitemia or contain mixed species (22). PCR can
also be performed on dried blood spots, which are convenient
for collection, storage, and transport. Nonetheless, PCR has a
long turnaround time, making it an impractical tool for clinical
care of individual patients. One exception would be real-time
PCR, which has a short turnaround time but carries with it cost
and capacity constraints that make it unavailable for rapid
diagnosis in most settings. However, there is a potential role
for PCR in situations where large numbers of samples are
being screened: a high-throughput system could allow accu-
rate, rapid, and cost-effective assessments to quantify preva-
lence and identify species.
The need for a high-throughput method to detect malaria
parasites is especially important for surveillance in low-trans-
mission and elimination settings, where low prevalence renders
diagnostic testing at the individual sample level impractical and
inefficient. Detection methods based on pooled nucleic acid
could provide a simple solution. The pooling of sera or plasma
specimens has long been used to improve the accuracy, cost-
effectiveness, and throughput of screening for many infections
(e.g., HIV-1, hepatitis B virus, hepatitis C virus, and West Nile
virus) in low-prevalence settings, such as blood banks (4, 26).
We recently reported methods for pooled analysis of dried
blood spots for HIV-1 nucleic acids (1, 18).
The goal of this study was to develop and apply a novel
PCR-based pooling strategy for the detection of malaria par-
asites using dried blood spots. We first established reference
standards by using laboratory strains to create dried blood
spots with known Plasmodium falciparum parasite densities.
After extracting DNA from pools of dried blood spots, we
compared the sensitivities and specificities of different nucleic
acid amplification tests. The most robust pooling strategy was
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identified and then applied to 891 field samples collected using
passive and active surveillance from a cohort of 77 children
living in Kampala, Uganda—a city with relatively low malaria
endemicity—who were followed for up to 2 years. The results
were compared to those obtained by microscopy.
MATERIALS AND METHODS
Preparation of control dried blood spots with known parasite densities. P.
falciparum strain W2 parasites were cultured and synchronized at the ring stage
using standard methods (14). Parasitemia was determined using flow cytometry.
Positive controls were prepared by mixing infected red blood cells with unin-
fected whole blood to create parasite densities of 10 and 100 parasites/l. Neg-
ative controls were prepared using blood from uninfected persons. To simulate
collection of dried blood spots in the field, blood was spotted in 20-l aliquots
onto Whatman 3MM filter paper, air dried overnight, and stored at room tem-
perature in plastic bags sealed with desiccant. Plasmodium vivax dried blood
spots were obtained from the Centers for Disease Control and Prevention of the
Republic of Korea. Punches 3 mm in diameter were removed from the dried
blood spots using handheld hole punches.
Optimizing the pooling methodology. We used the laboratory-prepared P.
falciparum blood samples to compare several DNA extraction and amplification
methods across a range of pool sizes (10, 50, and 100) and parasite densities (0,
10, and 100 parasites/l). Once the optimal strategy was identified, additional
tests were performed in pool sizes of 5, 10, 25, and 50 to generate estimates of
sensitivity. Pool sizes of 100 did not easily fit into the 1.5-ml tubes used for
extraction and were therefore not pursued further. The optimal strategy was also
used to test the P. vivax clinical samples in pools of 25.
Test pools contained one punch from a positive dried blood spot, the remain-
der being punches from malaria-negative dried blood spots. A single DNA
extraction was performed on each pool of punches, and the extraction product
was used as a template for amplification.
Two different DNA extraction methods were evaluated: the saponin/Chelex
method (24) and the QIAamp DNA minikit (Qiagen, CA). The sensitivities of
four detection methods were compared: two nested techniques, 18S ribosomal
DNA (rDNA) nested PCR (29) and cytochrome b nested PCR (30), and two
single-round techniques, 18S rDNA PCR (21) and 18S rDNA probe-based real-
time PCR (28). Real-time amplification was performed using a 7500 Real-Time
PCR System (Applied Biosystems, CA). Other PCR amplifications were per-
formed on a Bio-Rad Thermocycler C1000 or S1000 (Bio-Rad Laboratories,
CA). Amplification products were detected by agarose gel electrophoresis or via
real-time PCR, as appropriate, by persons blinded to the status of the specimens.
Field samples from the study cohort. Once Chelex extraction followed by
cytochrome b nested PCR was identified as the optimal strategy, it was used to
test dried blood spots collected using passive and active surveillance of a pedi-
atric cohort randomly selected from the Mulago III parish of Kampala, Uganda
(T. D. Clark, D. Njama-Meya, D. B. Nzarubara, C. Maiteki-Sebuguzi, B. Green-
house, S. G. Staedke, M. R. Kamya, G. Dorsey, and P. J. Rosenthal, unpublished
data). Children were enrolled from February to May 2007 and followed until
December 2008 (7). As part of passive surveillance, blood smears and dried
blood spots were collected whenever the children presented to the clinic with a
new episode of fever (subjective or based on a temperature of 38°C in the
previous 24 h). As part of active surveillance, blood smears and dried blood spots
were collected from asymptomatic children presenting for routine visits approx-
imately every 90 days. Final microscopy results were based on a rigorous quality
control system that included rereading of all blood smears by a second micros-
copist and resolution of any discrepancies between the first and second readings
by a third microscopist. To prepare dried blood spots, blood was blotted on
Whatman 3MM filter paper, air dried, and stored at room temperature in plastic
bags sealed with desiccant.
Pooling strategy applied to field samples. We used a three-stage hierarchical
pooling strategy (23). Samples were first divided into master pools with the
optimal size dependent on the estimated prevalence, as well as the sensitivity and
specificity of the pooling assay (33, 34). Positive master pools were divided into
subpools, with the optimal subpool size being the square root of the master pool
size. Positive subpools were tested as individual specimens. Based on the known
prevalence by microscopy in this study (5%) and the expected high sensitivity
and specificity of the assay (100% for parasite densities of 100 parasites/l), the
most efficient master and subpool sizes were determined to be nine and three,
respectively (34).
In the final step, we performed a restriction digestion, as the cytochrome b
PCR assay begins with genus-specific detection, followed by species determina-
tion based on AluI restriction digestion (31). Species were identified by compar-
ing digestion patterns to those of known controls. (See the supplemental material
for a detailed protocol of the pooling strategy.)
Statistical analysis. Data were analyzed using Stata 10.0 (StataCorp LP, TX).
P values were generated using a chi-square or Fisher’s exact test as appropriate.
RESULTS
Optimizing the pooling strategy. Pooled Chelex extraction
of DNA followed by cytochrome b nested PCR was identified
as the most robust strategy. In pools containing one very low-P.
falciparum-parasitemic sample (10 parasites/l), the sensitivity
ranged from 40% with pools of 100 to 93% with pools of 10.
For all pool sizes that included one low-P. falciparum-para-
sitemic sample (100 parasites/l), 100% sensitivity was
achieved. The specificity was 100% throughout (Table 1). Sen-
sitivity results from other DNA extraction/PCR combinations
are shown in the supplemental material.
We also evaluated field samples from three patients diag-
nosed with P. vivax infection in a similar manner. The sensi-
tivities for the detection of one positive sample in pools of 25
were 100% (10/10) when the sample had 640 parasites/l, 90%
(9/10) at 2,000 parasites/l, and 100% at 8,118 parasites/l
(10/10).
Cohort characteristics. A total of 419 samples were col-
lected through passive surveillance in patients who presented
with fever, and 472 samples were collected through active
surveillance in asymptomatic subjects. The cohort included 77
children; the mean age at the start of the study period was 3
years (range, 1 to 10 years), and the median time of follow-up
was 663 days (range, 616 to 730 days).
Application of pooling strategy to dried blood spots col-
lected from the cohort. We used a three-stage pooling strategy,
excluding samples that tested negative at each stage (Fig. 1).
Ultimately, 50 of 891 dried blood spot samples were identified
as positive, resulting in an overall prevalence of 5.6%. The
efficiency of pooling, calculated as the number of tests per-
formed per total number of individual samples evaluated, was
0.33. In other words, our pooling strategy, compared to per-
forming individual PCRs on all samples, reduced labor and
supply costs by about two-thirds.
Passive surveillance. Of the 50 samples that were positive by
pooling, 35 were among the 419 samples collected from febrile
patients. All 35 of these samples were also positive by micros-
copy. Five samples that were positive by microscopy were neg-
ative by pooling (Table 2). The incidence of symptomatic in-
TABLE 1. Sensitivity and specificity of pooled Chelex DNA
extraction followed by cytochrome b nested PCR
Pool size




100 p/l 10 p/l 0 p/l
50 100 70 100
25 100 65 100
10 100 93 100
5 100 80 100
a n refers to independent pooled extractions followed by PCR; p/l, para-
sites/l.
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fections was 0.32 case per person-year by microscopy versus
0.28 case per person-year by our pooling strategy.
Of the 5 microscopy-positive samples that were missed by
pooling, 3 were excluded at the master pool level and 2 at the
subpool level. These samples had two characteristics: they had
low parasite densities (64, 400, 400, 880, and 5,680 parasites/l)
and were tested more than 2 years after collection. Among all
40 microscopy-positive samples from symptomatic subjects, we
compared those that had both characteristics (parasite density
of less than 6,000 parasites/l and storage for more than 2
years) with those that did not. The sensitivity of pooling for
detection of parasites was 29% (2/7) among samples with both
characteristics versus 100% (33/33) among samples without
both characteristics (P  0.001).
Active surveillance. Of the 50 samples positive by pooling, 15
were among the 472 samples collected from asymptomatic
patients. Four were detected by microscopy, and 11 were not.
Pooling successfully identified all the microscopy-positive sam-
ples (Table 2). The prevalence of asymptomatic infections was
0.8% by microscopy versus 3.2% by pooling (P  0.01).
For the 11 samples that were negative by microscopy but
positive by pooling, reviews of the medical histories suggested
that many represented asymptomatic parasitemia. Two sam-
ples were from patients who presented symptomatic with pos-
itive blood smears 5 to 11 days later. Five samples represented
consecutive collections from two patients. One sample was
obtained from a patient who had gametocytes on smear 3 days
later. Two samples were obtained at enrollment, when the
prevalence of asymptomatic parasitemia was high in the cohort
(8). The last sample was from a patient who did not have any
follow-up smears; we were therefore unable to assess the pos-
sibility of persistent infection.
Species determination. Species determination was based on
AluI restriction digestion of the amplified cytochrome b gene
(Fig. 2). Among the 35 samples that were positive by both
microscopy and pooling, there was agreement in the detection
of 31 P. falciparum infections and 1 Plasmodium ovale infec-
tion. Three samples identified as P. falciparum by microscopy
were identified by pooling as 2 P. ovale infections and 1 mixed
P. falciparum-P. vivax infection. Of the 11 asymptomatic cases
positive by PCR but not microscopy, there were 7 P. falciparum
infections, 1 Plasmodium malariae infection, 1 P. ovale infec-
tion, and 2 mixed P. falciparum-P. ovale infections.
DISCUSSION
We developed and applied a novel strategy for PCR-based
pooled detection of malaria parasites using dried blood spots.
After evaluating numerous methods on laboratory-prepared
FIG. 1. Schematic of pooling strategy applied to cohort samples.
The white circles represent Plasmodium-negative dried blood spots
(DBS); the solid black circles represent Plasmodium-positive dried
blood spots. At each stage, the dried blood spots were extracted to-
gether. The DNA extraction product was then used as a template for
cytochrome b nested PCR.
TABLE 2. Microscopy versus PCR-based pooling in passive
surveillance of symptomatic subjects and active





Passive  35 0 35
 5 379 384
Total 40 379 419
Active  4 11 15
 0 457 457
Total 4 468 472
a , positive; , negative.
FIG. 2. AluI digestion for species determination. P. ovale digestion
patterns may vary depending on the strain type. Our samples showed
a pattern that correlates with a published sequence (GenBank acces-
sion number AB182497). However, another sequence (GenBank ac-
cession number AB182496) would produce a different AluI restriction
pattern with expected band sizes of 205 and 610 bp. Pf, P. falciparum;
Pm, P. malariae; Po, P. ovale; Pv, P. vivax.
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samples, we found the optimal strategy to be Chelex extraction
of pooled 3-mm punches from dried blood spots, followed by
cytochrome b nested PCR for Plasmodium detection and AluI
restriction digestion for species determination. Because of the
sensitive detection associated with this method, we were able
to reliably identify a single 100-parasite/l sample in pool sizes
up to 50. We then applied the optimized strategy to 891 field
samples collected through both passive and active surveillance
in a well-characterized pediatric cohort. Compared to micros-
copy, we detected fewer cases among symptomatic patients
(35/419 versus 40/419), missing 5 microscopy-positive samples
that were all stored for longer than 2 years and that tended to
have lower parasitemia. Among asymptomatic patients, we
detected 3 times as many infections as by microscopy (15/472
versus 4/472). The pooling strategy also allowed improved de-
tection of non-falciparum and mixed infections.
Monitoring, evaluation, and appropriate targeting of inter-
ventions depend on accurate surveillance, particularly in low-
transmission and elimination settings. Compared to micros-
copy and RDTs, PCR is well known to provide improved
sensitivity and specificity (22). However, the long turnaround
time for PCR makes it impractical for rapid diagnosis of indi-
vidual patients, and in surveillance settings, it is labor and cost
prohibitive to perform individual PCRs on large numbers of
samples. Pooling is a simple strategy that has recently been
applied to the detection of malaria parasites in surveillance
settings. In an exploratory study using 18S rDNA nested PCR
and pool sizes of 10, there was successful detection of 6 posi-
tives among 200 serum samples (2). In a larger study that
utilized dried blood spot samples collected from a cohort of
pregnant women, individual DNA extractions were performed,
and then the extraction products from 4 samples were pooled
in a single 18S rDNA real-time PCR. Among 1,092 microsco-
py-negative samples that were tested by pooling, 35 positive
samples were identified. Among 176 microscopy-positive sam-
ples that were tested in individual PCRs, 74 were positive (32).
Our study offers advances over prior studies. Importantly, we
used easily collected dried blood spots, optimized strategies
after comparison of multiple related methods, validated the
sensitivity and specificity of our strategy by comparison with
laboratory controls, and were able to pool large numbers of
samples.
The inexpensive Chelex method performed better than the
commonly used spin column system, and at lower parasite
densities and higher pool sizes, cytochrome b nested PCR
provided the highest sensitivity. Others have also found the
cytochrome b method to be more sensitive than 18S rDNA
nested PCR (13, 30), likely because there are more copies of
the gene in each parasite (15, 25). It also performed better than
two other single-round PCR methods, including one real-time
method. The cytochrome b PCR method is also advantageous
in that amplification targets a DNA sequence common to all
species (30). For this reason, our pooling strategy requires tests
of speciation only at the final stage of pooling, further simpli-
fying the assay.
Unlike published strategies in which pooling occurred at the
time of PCR detection (32, 34), we pooled at the time of DNA
extraction. By using this approach and by using optimal pool
sizes based on the anticipated prevalence, our strategy allowed
pooled detection of large numbers of samples and reduced
much of the labor associated with DNA extraction. The find-
ings that sensitivity was maintained and that experiments were
easy to perform at pool sizes up to 50 are particularly impor-
tant, since the ability to pool many samples dramatically in-
creases efficiency, especially in low-prevalence settings. For
example, if our pooling strategy were used in a setting where
the prevalence of parasitemia was 0.01%, using pool sizes of 49
would result in an efficiency of 0.05, saving approximately 95%
of the labor and supply costs (34). Also, of particular relevance
to low-prevalence settings, our proposed strategy can poten-
tially provide improved specificity, given that an individual
sample must be amplified by PCR three times to be identified
as positive. Specificity was not a problem in our study, but false
positives could occur in situations where there is cross-contam-
ination. The fact that our strategy involves pooled DNA ex-
tractions with resampling from the original dried blood spot at
each stage is a further advance over methods that require
resampling from a potentially contaminated DNA extraction
product.
When applied to field samples, we found that the sensitivity
of low-parasitemic samples stored for at least 2 years was
compromised, highlighting the possibility of DNA degradation
with long-term storage of samples. No microscopy-positive
samples stored for less than 2 years were missed by pooling,
suggesting that pooled testing of samples within 2 years of
collection is reliable. In addition, extremely low parasite den-
sities, around 10 parasites/l, may not be detected reliably,
likely due to the diluting effect of pooling. However, increased
sensitivity was demonstrated with smaller pool sizes (see Table
S1 in the supplemental material). Also, this strategy enabled
the detection of 11 submicroscopic infections, 6 of which were
detected in samples that had been stored for more than 2
years.
There are several potential applications for our pooling
strategy. First, it is a sensitive and high-throughput method
that can improve the detection of malaria infections in com-
munity surveys of parasite prevalence (12). Second, there is
potential for our pooling strategy to be used for quality assur-
ance of standard diagnostics in research or clinical settings
(17). Third, it allows the identification of asymptomatic sub-
microscopic infections. Similar to the results of a recently per-
formed systematic review of submicroscopic infections, we de-
tected about three times as many parasitemic samples as with
microscopy (20). Submicroscopic asymptomatic infections are
known to be a major driver of malaria transmission (3, 6, 29),
but how and to what extent remains unclear. Using samples
from easily collected dried blood spots, our pooling strategy
can facilitate further studies on this topic.
Lastly, there are several possible applications of our pooling
strategy for malaria elimination programs. It can be applied in
mass screening and treatment of asymptomatic populations,
which is emerging as a potentially important strategy to facilitate
malaria elimination (19). For example, mass screening and treat-
ment are being applied as part of recent efforts to eliminate
artemisinin-resistant parasites that have emerged at the Thai-
Cambodian border (World Health Organization, presented at the
Strategy for the Containment of Artemisinin Tolerant Malaria
Parasites in South-East Asia Project Meeting, Pailin, Cambodia,
2009). Areas that have already achieved elimination have insti-
tuted high-volume border-screening programs in order to prevent
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reintroduction of malaria. Mauritius (5), Oman (27), and Singa-
pore (16) are examples of countries that perform individual
screening of asymptomatic visitors and/or immigrants using mi-
croscopy or RDTs. While such mass screening strategies are fea-
sible using existing techniques in resource-rich countries, use of
the proposed pooling strategy may put mass screening within the
reach of resource-poor sites (5, 35).
In summary, we have developed and applied a robust and novel
strategy for high-throughput PCR-based detection of malaria par-
asites using dried blood spots. Compared to microscopy, our
PCR-based pooling strategy allows improved detection of species
and, most importantly, asymptomatic infections. There is a need
for improved surveillance in low-transmission settings, and our
proposed strategy holds promise as a simple new tool to facilitate
progress toward malaria elimination.
ACKNOWLEDGMENTS
This work was supported by grants from the Pediatric Infectious
Diseases Society, National Institutes of Health (grants U01 AI52142,
R01 MH068686, and P01 AI071713), the Bill and Melinda Gates
Foundation (grant 48820), and the University of California, San Fran-
cisco, Dean’s Research Fellowship Program.
We thank Nicolas Steenkeste for sharing details of the cytochrome
b nested PCR and AluI digestion for species detection, Ric Price for
sharing standard operating procedures of other tested PCR methods,
and Jung-Yeon Kim for sharing of clinical P. vivax samples. We thank
Phil Rosenthal and Jay Tureen for their guidance and helpful review of
the manuscript and Richard Feachem for his support of the project.
We declare that we have no conflicts of interest for this article.
REFERENCES
1. Bebell, L. M., C. D. Pilcher, G. Dorsey, D. Havlir, M. R. Kamya, M. P. Busch,
J. D. Williams, C. T. Nugent, C. Bentsen, P. J. Rosenthal, and E. D. Char-
lebois. 2010. Acute HIV-1 infection is highly prevalent in Ugandan adults
with suspected malaria. AIDS 24:1945–1952.
2. Bharti, A. R., S. L. Letendre, K. P. Patra, J. M. Vinetz, and D. M. Smith.
2009. Malaria diagnosis by a polymerase chain reaction-based assay using a
pooling strategy. Am. J. Trop. Med. Hyg. 81:754–757.
3. Boudin, C., M. Olivier, J. F. Molez, J. P. Chiron, and P. Ambroise-Thomas.
1993. High human malarial infectivity to laboratory-bred Anopheles gambiae
in a village in Burkina Faso. Am. J. Trop. Med. Hyg. 48:700–706.
4. Busch, M. P., D. J. Wright, B. Custer, L. H. Tobler, S. L. Stramer, S. H.
Kleinman, H. E. Prince, C. Bianco, G. Foster, L. R. Petersen, G. Nemo, and
S. A. Glynn. 2006. West Nile virus infections projected from blood donor
screening data, United States, 2003. Emerg. Infect. Dis. 12:395–402.
4a.Clark, T. D., D. Njama-Meya, B. Nzarubara, C. Maiteki-Sebuguzi, B. Green-
house, S. G. Staedke, M. R. Kamya, G. Dorsey, and P. J. Rosenthal. 2010.
Incidence of malaria and efficacy of combination antimalarial therapies over
4 years in an urban cohort of Ugandan children. PLoS One 5:e11759.
5. Cohen, J. M., D. L. Smith, A. Vallely, G. Taleo, G. Malefoasi, and O. Sabot.
2009. Holding the line, p. 40–60. In R. G. A. Feachem, A. Phillips, and G. A.
Targett (ed.), A prospectus on malaria elimination. Global Health Group,
San Francisco, CA.
6. Coleman, R. E., C. Kumpitak, A. Ponlawat, N. Maneechai, V. Phunkitchar,
N. Rachapaew, G. Zollner, and J. Sattabongkot. 2004. Infectivity of asymp-
tomatic Plasmodium-infected human populations to Anopheles dirus mos-
quitoes in western Thailand. J. Med. Entomol. 41:201–208.
7. Davis, J. C., T. D. Clark, S. K. Kemble, N. Talemwa, D. Njama-Meya, S. G.
Staedke, and G. Dorsey. 2006. Longitudinal study of urban malaria in a
cohort of Ugandan children: description of study site, census and recruit-
ment. Malar. J. 5:18.
8. Dorsey, G., S. Staedke, T. D. Clark, D. Njama-Meya, B. Nzarubara, C.
Maiteki-Sebuguzi, C. Dokomajilar, M. R. Kamya, and P. J. Rosenthal. 2007.
Combination therapy for uncomplicated falciparum malaria in Ugandan
children: a randomized trial. JAMA 297:2210–2219.
9. Feachem, R., and O. Sabot. 2008. A new global malaria eradication strategy.
Lancet 371:1633–1635.
10. Feachem, R. G. A., and the Malaria Elimination Group. 2009. Shrinking the
malaria map, a guide on malaria elimination for policy makers. Global
Health Group, San Francisco, CA.
11. Greenwood, B. M. 2008. Control to elimination: implications for malaria
research. Trends Parasitol. 24:449–454.
12. Guerra, C. A., P. W. Gikandi, A. J. Tatem, A. M. Noor, D. L. Smith, S. I. Hay,
and R. W. Snow. 2008. The limits and intensity of Plasmodium falciparum
transmission: implications for malaria control and elimination worldwide.
PLoS Med. 5:e38.
13. Hasan, A. U., S. Suguri, J. Sattabongkot, C. Fujimoto, M. Amakawa, M.
Harada, and H. Ohmae. 2009. Implementation of a novel PCR based
method for detecting malaria parasites from naturally infected mosquitoes in
Papua New Guinea. Malar. J. 8:182.
14. Jensen, J. B. 2002. In vitro culture of Plasmodium parasites. Methods Mol.
Med. 72:477–488.
15. Langsley, G., J. E. Hyde, M. Goman, and J. G. Scaife. 1983. Cloning and
characterisation of the rRNA genes from the human malaria parasite Plas-
modium falciparum. Nucleic Acids Res. 11:8703–8717.
16. Lee, Y. C., C. S. Tang, L. W. Ang, H. K. Han, L. James, and K. T. Goh. 2009.
Epidemiological characteristics of imported and locally-acquired malaria in
Singapore. Ann. Acad. Med. Singapore 38:840–849.
17. McMorrow, M. L., M. I. Masanja, E. Kahigwa, S. M. Abdulla, and S. P.
Kachur. 2010. Quality assurance of rapid diagnostic tests for malaria in
routine patient care in rural Tanzania. Am. J. Trop. Med. Hyg. 82:151–155.
18. Nugent, C. T., J. Dockter, F. Bernardin, R. Hecht, D. Smith, E. Delwart, C.
Pilcher, D. Richman, M. Busch, and C. Giachetti. 2009. Detection of HIV-1
in alternative specimen types using the APTIMA HIV-1 RNA Qualitative
Assay. J. Virol. Methods 159:10–14.
19. Ogutu, B., A. B. Tiono, M. Makanga, Z. Premji, A. D. Gbadoe, D. Ubben,
A. C. Marrast, and O. Gaye. 2010. Treatment of asymptomatic carriers with
artemether-lumefantrine: an opportunity to reduce the burden of malaria?
Malar. J. 9:30.
20. Okell, L. C., A. C. Ghani, E. Lyons, and C. J. Drakeley. 2009. Submicroscopic
infection in Plasmodium falciparum-endemic populations: a systematic re-
view and meta-analysis. J. Infect. Dis. 200:1509–1517.
21. Padley, D., A. H. Moody, P. L. Chiodini, and J. Saldanha. 2003. Use of a
rapid, single-round, multiplex PCR to detect malarial parasites and identify
the species present. Ann. Trop. Med. Parasitol. 97:131–137.
22. Perkins, M. D., and D. Bell. 2008. Working without a blindfold: the critical
role of diagnostics in malaria control. Malar. J. 7(Suppl. 1):S5.
23. Pilcher, C. D., J. J. Eron, Jr., S. Galvin, C. Gay, and M. S. Cohen. 2004.
Acute HIV revisited: new opportunities for treatment and prevention.
J. Clin. Invest. 113:937–945.
24. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995.
Pyrimethamine and proguanil resistance-conferring mutations in Plasmo-
dium falciparum dihydrofolate reductase: polymerase chain reaction meth-
ods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565–568.
25. Preiser, P. R., R. J. Wilson, P. W. Moore, S. McCready, M. A. Hajibagheri, K. J.
Blight, M. Strath, and D. H. Williamson. 1996. Recombination associated with
replication of malarial mitochondrial DNA. EMBO J. 15:684–693.
26. Quinn, T. C., R. Brookmeyer, R. Kline, M. Shepherd, R. Paranjape, S.
Mehendale, D. A. Gadkari, and R. Bollinger. 2000. Feasibility of pooling sera
for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and esti-
mate HIV incidence. AIDS 14:2751–2757.
27. Roll Back Malaria Partnership. 2008. Elimination and eradication: achiev-
ing zero transmission, Global malaria action plan, part II.3. Roll Back Ma-
laria, Geneva, Switzerland.
28. Shokoples, S. E., M. Ndao, K. Kowalewska-Grochowska, and S. K. Yanow.
2009. Multiplexed real-time PCR assay for discrimination of Plasmodium
species with improved sensitivity for mixed infections. J. Clin. Microbiol.
47:975–980.
29. Snounou, G., S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro, V. E. do
Rosario, S. Thaithong, and K. N. Brown. 1993. High sensitivity of detection
of human malaria parasites by the use of nested polymerase chain reaction.
Mol. Biochem. Parasitol. 61:315–320.
30. Steenkeste, N., S. Incardona, S. Chy, L. Duval, M. T. Ekala, P. Lim, S.
Hewitt, T. Sochantha, D. Socheat, C. Rogier, O. Mercereau-Puijalon, T.
Fandeur, and F. Ariey. 2009. Towards high-throughput molecular detection
of Plasmodium: new approaches and molecular markers. Malar. J. 8:86.
31. Steenkeste, N., W. O. Rogers, L. Okell, I. Jeanne, S. Incardona, L. Duval, S.
Chy, S. Hewitt, M. Chou, D. Socheat, F. X. Babin, F. Ariey, and C. Rogier.
2010. Sub-microscopic malaria cases and mixed malaria infection in a remote
area of high malaria endemicity in Rattanakiri province, Cambodia: impli-
cation for malaria elimination. Malar. J. 9:108.
32. Taylor, S. M., J. J. Juliano, P. A. Trottman, J. B. Griffin, S. H. Landis, P.
Kitsa, A. K. Tshefu, and S. R. Meshnick. 2010. High-throughput pooling and
real-time PCR-based strategy for malaria detection. J. Clin. Microbiol. 48:
512–519.
33. Westreich, D. J., M. G. Hudgens, S. A. Fiscus, and C. D. Pilcher. 1 March
2010, posting date. Optimal pooling strategies for acute HIV—web calcula-
tor v1.0. http://www.bios.unc.edu/mhudgens/optimal.pooling.htm.
34. Westreich, D. J., M. G. Hudgens, S. A. Fiscus, and C. D. Pilcher. 2008.
Optimizing screening for acute human immunodeficiency virus infection
with pooled nucleic acid amplification tests. J. Clin. Microbiol. 46:1785–1792.
35. Zanzibar Malaria Control Program. 2009. Malaria elimination in Zanzibar:
a feasibility assessment. Ministry of Health and Social Welfare, Zanzibar
City, Zanzibar.
VOL. 48, 2010 POOLING STRATEGY FOR DETECTING MALARIA PARASITES 3543
